Global Age Related Macular Degeneration Market Professional Survey Report 2016

July 2016 | 113 pages | ID: G95B85F07A6EN
QYResearch

Abstracts

This report mainly covers the following

Segment regions including (the separated region report can also be offered)

• North America
• Europe
• Japan
• China
• Southeast Asia
• India

The players list (Partly, Players you are interested in can also be added)

• Achillion Pharmaceuticals, Inc.
• Bayer AG
• Charlesson LLC.
• Digna Biotech, S.L.
• Eleven Biotherapeutics Inc.
• Foamix Pharmaceuticals Ltd.
• Gene Signal International SA
• HanAll Biopharma Co., Ltd.
• Icon Bioscience, Inc.
• Johnson & Johnson
• Kala Pharmaceuticals, Inc.
• Lpath, Inc.
• Merz Pharma GmbH & Co. KgaA
• Neovacs SA
• Ocata Therapeutics, Inc.
• PanOptica, Inc.
• Pfenex Inc.
• Quark Pharmaceuticals, Inc.
• R-Tech Ueno, Ltd.
• Sumitomo Dainippon Pharma Co., Ltd.
• ThromboGenics NV
• VasGene Therapeutics, Inc.
• Wellstat Ophthalmics Corporation

With 23 top producers.

Data including (both global and regions): Market Size (both volume - K Dose and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Dose, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Contents

1 INDUSTRY OVERVIEW OF AGE RELATED MACULAR DEGENERATION

1.1 Definition and Specifications of Age Related Macular Degeneration
  1.1.1 Definition of Age Related Macular Degeneration
  1.1.2 Specifications of Age Related Macular Degeneration
1.2 Classification of Age Related Macular Degeneration
1.3 Applications of Age Related Macular Degeneration
1.4 Industry Chain Structure of Age Related Macular Degeneration
1.5 Industry Overview and Major Regions Status of Age Related Macular Degeneration
  1.5.1 Industry Overview of Age Related Macular Degeneration
  1.5.2 Global Major Regions Status of Age Related Macular Degeneration
1.6 Industry Policy Analysis of Age Related Macular Degeneration
1.7 Industry News Analysis of Age Related Macular Degeneration

2 MANUFACTURING COST STRUCTURE ANALYSIS OF AGE RELATED MACULAR DEGENERATION

2.1 Raw Material Suppliers and Price Analysis of Age Related Macular Degeneration
2.2 Equipment Suppliers and Price Analysis of Age Related Macular Degeneration
2.3 Labor Cost Analysis of Age Related Macular Degeneration
2.4 Other Costs Analysis of Age Related Macular Degeneration
2.5 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration
2.6 Manufacturing Process Analysis of Age Related Macular Degeneration

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF AGE RELATED MACULAR DEGENERATION

3.1 Capacity and Commercial Production Date of Global Age Related Macular Degeneration Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Age Related Macular Degeneration Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Age Related Macular Degeneration Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Age Related Macular Degeneration Major Manufacturers in 2015

4 GLOBAL AGE RELATED MACULAR DEGENERATION OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Age Related Macular Degeneration Capacity and Growth Rate Analysis
  4.2.2 2015 Age Related Macular Degeneration Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Age Related Macular Degeneration Sales and Growth Rate Analysis
  4.3.2 2015 Age Related Macular Degeneration Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Age Related Macular Degeneration Sales Price
  4.4.2 2015 Age Related Macular Degeneration Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Age Related Macular Degeneration Gross Margin
  4.5.2 2015 Age Related Macular Degeneration Gross Margin Analysis (Company Segment)

5 AGE RELATED MACULAR DEGENERATION REGIONAL MARKET ANALYSIS

5.1 North America Age Related Macular Degeneration Market Analysis
  5.1.1 North America Age Related Macular Degeneration Market Overview
  5.1.2 North America 2011-2016E Age Related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Age Related Macular Degeneration Sales Price Analysis
  5.1.4 North America 2015 Age Related Macular Degeneration Market Share Analysis
5.2 Europe Age Related Macular Degeneration Market Analysis
  5.2.1 Europe Age Related Macular Degeneration Market Overview
  5.2.2 Europe 2011-2016E Age Related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2011-2016E Age Related Macular Degeneration Sales Price Analysis
  5.2.4 Europe 2015 Age Related Macular Degeneration Market Share Analysis
5.3 Japan Age Related Macular Degeneration Market Analysis
  5.3.1 Japan Age Related Macular Degeneration Market Overview
  5.3.2 Japan 2011-2016E Age Related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Japan 2011-2016E Age Related Macular Degeneration Sales Price Analysis
  5.3.4 Japan 2015 Age Related Macular Degeneration Market Share Analysis
5.4 China Age Related Macular Degeneration Market Analysis
  5.4.1 China Age Related Macular Degeneration Market Overview
  5.4.2 China 2011-2016E Age Related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 China 2011-2016E Age Related Macular Degeneration Sales Price Analysis
  5.4.4 China 2015 Age Related Macular Degeneration Market Share Analysis
5.5 Southeast Asia Age Related Macular Degeneration Market Analysis
  5.5.1 Southeast Asia Age Related Macular Degeneration Market Overview
  5.5.2 Southeast Asia 2011-2016E Age Related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2011-2016E Age Related Macular Degeneration Sales Price Analysis
  5.5.4 Southeast Asia 2015 Age Related Macular Degeneration Market Share Analysis
5.6 India Age Related Macular Degeneration Market Analysis
  5.6.1 India Age Related Macular Degeneration Market Overview
  5.6.2 India 2011-2016E Age Related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Age Related Macular Degeneration Sales Price Analysis
  5.6.4 India 2015 Age Related Macular Degeneration Market Share Analysis

6 GLOBAL 2011-2016E AGE RELATED MACULAR DEGENERATION SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Age Related Macular Degeneration Sales by Type
6.2 Different Types Age Related Macular Degeneration Product Interview Price Analysis
6.3 Different Types Age Related Macular Degeneration Product Driving Factors Analysis

7 GLOBAL 2011-2016E AGE RELATED MACULAR DEGENERATION SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF AGE RELATED MACULAR DEGENERATION

8.1 Achillion Pharmaceuticals, Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Achillion Pharmaceuticals, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Achillion Pharmaceuticals, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.2 Bayer AG
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Bayer AG 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bayer AG 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.3 Charlesson LLC.
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Charlesson LLC. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Charlesson LLC. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.4 Digna Biotech, S.L.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Digna Biotech, S.L. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Digna Biotech, S.L. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.5 Eleven Biotherapeutics Inc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Eleven Biotherapeutics Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Eleven Biotherapeutics Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.6 Foamix Pharmaceuticals Ltd.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Foamix Pharmaceuticals Ltd. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Foamix Pharmaceuticals Ltd. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.7 Gene Signal International SA
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Gene Signal International SA 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Gene Signal International SA 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.8 HanAll Biopharma Co., Ltd.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 HanAll Biopharma Co., Ltd. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 HanAll Biopharma Co., Ltd. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.9 Icon Bioscience, Inc.
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 Icon Bioscience, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Icon Bioscience, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.10 Johnson & Johnson
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
  8.10.3 Johnson & Johnson 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Johnson & Johnson 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.11 Kala Pharmaceuticals, Inc.
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
  8.11.3 Kala Pharmaceuticals, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Kala Pharmaceuticals, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.12 Lpath, Inc.
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
  8.12.3 Lpath, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Lpath, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.13 Merz Pharma GmbH & Co. KgaA
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
  8.13.3 Merz Pharma GmbH & Co. KgaA 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 Merz Pharma GmbH & Co. KgaA 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.14 Neovacs SA
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
  8.14.3 Neovacs SA 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.14.4 Neovacs SA 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.15 Ocata Therapeutics, Inc.
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
  8.15.3 Ocata Therapeutics, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.15.4 Ocata Therapeutics, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.16 PanOptica, Inc.
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
  8.16.3 PanOptica, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.16.4 PanOptica, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.17 Pfenex Inc.
  8.17.1 Company Profile
  8.17.2 Product Picture and Specifications
  8.17.3 Pfenex Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.17.4 Pfenex Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.18 Quark Pharmaceuticals, Inc.
  8.18.1 Company Profile
  8.18.2 Product Picture and Specifications
  8.18.3 Quark Pharmaceuticals, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.18.4 Quark Pharmaceuticals, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.19 R-Tech Ueno, Ltd.
  8.19.1 Company Profile
  8.19.2 Product Picture and Specifications
  8.19.3 R-Tech Ueno, Ltd. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.19.4 R-Tech Ueno, Ltd. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.20 Sumitomo Dainippon Pharma Co., Ltd.
  8.20.1 Company Profile
  8.20.2 Product Picture and Specifications
  8.20.3 Sumitomo Dainippon Pharma Co., Ltd. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.20.4 Sumitomo Dainippon Pharma Co., Ltd. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.21 ThromboGenics NV
  8.21.1 Company Profile
  8.21.2 Product Picture and Specifications
  8.21.3 ThromboGenics NV 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.21.4 ThromboGenics NV 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.22 VasGene Therapeutics, Inc.
  8.22.1 Company Profile
  8.22.2 Product Picture and Specifications
  8.22.3 VasGene Therapeutics, Inc. 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.22.4 VasGene Therapeutics, Inc. 2015 Age Related Macular Degeneration Business Region Distribution Analysis
8.23 Wellstat Ophthalmics Corporation
  8.23.1 Company Profile
  8.23.2 Product Picture and Specifications
  8.23.3 Wellstat Ophthalmics Corporation 2015 Age Related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.23.4 Wellstat Ophthalmics Corporation 2015 Age Related Macular Degeneration Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 North America 2016-2021 Age Related Macular Degeneration Consumption Forecast
  9.2.2 Europe 2016-2021 Age Related Macular Degeneration Consumption Forecast
  9.2.3 Japan 2016-2021 Age Related Macular Degeneration Consumption Forecast
  9.2.4 China 2016-2021 Age Related Macular Degeneration Consumption Forecast
  9.2.5 Southeast Asia 2016-2021 Age Related Macular Degeneration Consumption Forecast
  9.2.6 India 2016-2021 Age Related Macular Degeneration Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 AGE RELATED MACULAR DEGENERATION MARKETING MODEL ANALYSIS

10.1 Age Related Macular Degeneration Regional Marketing Model Analysis
10.2 Age Related Macular Degeneration International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Age Related Macular Degeneration by Regions
10.4 Age Related Macular Degeneration Supply Chain Analysis

11 CONSUMERS ANALYSIS OF AGE RELATED MACULAR DEGENERATION

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF AGE RELATED MACULAR DEGENERATION

12.1 New Project SWOT Analysis of Age Related Macular Degeneration
12.2 New Project Investment Feasibility Analysis of Age Related Macular Degeneration

13 CONCLUSION OF THE GLOBAL AGE RELATED MACULAR DEGENERATION MARKET PROFESSIONAL SURVEY REPORT 2016